<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11133">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962011</url>
  </required_header>
  <id_info>
    <org_study_id>ZIVH</org_study_id>
    <nct_id>NCT02962011</nct_id>
  </id_info>
  <brief_title>Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section</brief_title>
  <acronym>barbed</acronym>
  <official_title>Randomized Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziv Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ziv Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was an unblinded randomized controlled trial. Women were randomized to uterine closure
      with the knotless barbed suture (Stratafix PDS, Ethicon) or Vicryl (Ethicon) at the time of
      elective cesarean. The primary outcome was closure time of the uterine incision. Also
      measured were blood loss during incision closure and the use of additional hemostatic
      sutures. Informed consent was obtained
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uterine incision closure time</measure>
    <time_frame>5 months</time_frame>
    <description>uterine incision closure time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>uterine incision blood loss</measure>
    <time_frame>5 months</time_frame>
    <description>uterine incision blood loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemostatic suture use</measure>
    <time_frame>5 months</time_frame>
    <description>hemostatic suture use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Knotless barbed suture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>polyglactin 910</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vicryl</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Knotless barbed suture</intervention_name>
    <description>uterine incision closure</description>
    <arm_group_label>Knotless barbed suture</arm_group_label>
    <other_name>Stratafix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>polyglactin 910</intervention_name>
    <description>uterine incision closure</description>
    <arm_group_label>polyglactin 910</arm_group_label>
    <other_name>Vicryl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cesarean

          -  elective repeat cesarean

        Exclusion Criteria:

          -  emergent or urgent cesarean

          -  PROM

          -  chorioamninitis

          -  placental abruption

          -  placenta previa or accreta

          -  known uterine fibroids

          -  women with known medical problems such as coagulopathy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Peleg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziv Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Peleg</last_name>
    <phone>+972-4-6828959</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Ziv Medical Center</name>
      <address>
        <city>Zefat</city>
        <zip>13100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Peleg</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 10, 2016</lastchanged_date>
  <firstreceived_date>November 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ziv Hospital</investigator_affiliation>
    <investigator_full_name>David Peleg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cesarean, incision, suture,</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
